Literature DB >> 23032326

Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States.

Benjamin A Goldstein1, Cristina M Arce, Mark A Hlatky, Mintu Turakhia, Soko Setoguchi, Wolfgang C Winkelmayer.   

Abstract

BACKGROUND: One sixth of US dialysis patients 65 years of age have been diagnosed with atrial fibrillation/flutter (AF). Little is known, however, about the incidence of AF in this population. METHODS AND
RESULTS: We identified 258 605 older patients (≥67 years of age) with fee-for-service Medicare initiating dialysis in 1995 to 2007, who had not been diagnosed with AF within the previous 2 years. Patients were followed for newly diagnosed AF. Multivariable proportional hazard regression was used to examine temporal trends and associations of race and ethnicity with incident AF. We also studied temporal trends in the mortality and risk of ischemic stroke after new AF. Over 514 395 person-years of follow-up, 76 252 patients experienced incident AF for a crude AF incidence rate of 148/1000 person-years. Incidence of AF increased by 11% (95% confidence interval, 5-16) from 1995 to 2007. Compared with non-Hispanic whites, blacks (-30%), Asians (-19%), Native Americans (-42%), and Hispanics (-29%) all had lower rates of incident AF. Mortality after incident AF decreased by 22% from 1995 to 2008. Even more pronounced reductions were seen for incident ischemic stroke during these years.
CONCLUSIONS: The incidence of AF is high in older patients initiating dialysis in the United States and has been increasing over the 13 years of study. Mortality declined during that time but remained >50% during the first year after newly diagnosed AF. Because data on warfarin use were not available, we were unable to study whether trends toward better outcomes could be explained by higher rates of oral anticoagulation.

Entities:  

Mesh:

Year:  2012        PMID: 23032326      PMCID: PMC3640842          DOI: 10.1161/CIRCULATIONAHA.112.099606

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  46 in total

1.  Sensitivity of billing claims for cardiovascular disease events among kidney transplant recipients.

Authors:  Krista L Lentine; Mark A Schnitzler; Kevin C Abbott; Kosha Bramesfeld; Paula M Buchanan; Daniel C Brennan
Journal:  Clin J Am Soc Nephrol       Date:  2009-06-18       Impact factor: 8.237

2.  Left ventricular mass and ventricular remodeling among Hispanic subgroups compared with non-Hispanic blacks and whites: MESA (Multi-ethnic Study of Atherosclerosis).

Authors:  Carlos J Rodriguez; Ana V Diez-Roux; Andrew Moran; Zhezhen Jin; Richard A Kronmal; Joao Lima; Shunichi Homma; David A Bluemke; R Graham Barr
Journal:  J Am Coll Cardiol       Date:  2010-01-19       Impact factor: 24.094

Review 3.  Racial and ethnic disparities in end-stage kidney failure-survival paradoxes in African-Americans.

Authors:  Lawrence Agodoa; Paul Eggers
Journal:  Semin Dial       Date:  2007 Nov-Dec       Impact factor: 3.455

Review 4.  Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy.

Authors:  Jonathan Himmelfarb
Journal:  Semin Dial       Date:  2009 Nov-Dec       Impact factor: 3.455

5.  Atrial fibrillation in end-stage renal disease: an emerging problem.

Authors:  Panagiotis G Korantzopoulos; John A Goudevenos
Journal:  Kidney Int       Date:  2009-08       Impact factor: 10.612

6.  Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study.

Authors:  Hiroshi Watanabe; Toru Watanabe; Shigeru Sasaki; Kojiro Nagai; Dan M Roden; Yoshifusa Aizawa
Journal:  Am Heart J       Date:  2009-10       Impact factor: 4.749

7.  Relation of kidney function and albuminuria with atrial fibrillation (from the Heart and Soul Study).

Authors:  David D McManus; David C M Corteville; Michael G Shlipak; Mary A Whooley; Joachim H Ix
Journal:  Am J Cardiol       Date:  2009-12-01       Impact factor: 2.778

8.  Racial differences in the prevalence of atrial fibrillation among males.

Authors:  Ann M Borzecki; D Keith Bridgers; Jane M Liebschutz; Boris Kader; Lewis E Kazis; Dan R Berlowitz
Journal:  J Natl Med Assoc       Date:  2008-02       Impact factor: 1.798

9.  Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Alvaro Alonso; Sunil K Agarwal; Elsayed Z Soliman; Marietta Ambrose; Alanna M Chamberlain; Ronald J Prineas; Aaron R Folsom
Journal:  Am Heart J       Date:  2009-07       Impact factor: 4.749

Review 10.  Calcium balance during hemodialysis.

Authors:  Christopher W McIntyre
Journal:  Semin Dial       Date:  2008 Jan-Feb       Impact factor: 3.455

View more
  35 in total

Review 1.  Cardiovascular complications in chronic dialysis patients.

Authors:  Thomas A Mavrakanas; David M Charytan
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-11       Impact factor: 2.894

2.  Blood Pressure and Incident Atrial Fibrillation in Older Patients Initiating Hemodialysis.

Authors:  Tara I-Hsin Chang; Sai Liu; Medha Airy; Jingbo Niu; Mintu P Turakhia; Jennifer E Flythe; Maria E Montez-Rath; Wolfgang C Winkelmayer
Journal:  Clin J Am Soc Nephrol       Date:  2019-06-07       Impact factor: 8.237

3.  Racial/Ethnic Disparities in Atrial Fibrillation Treatment and Outcomes among Dialysis Patients in the United States.

Authors:  Salina P Waddy; Allen J Solomon; Adan Z Becerra; Julia B Ward; Kevin E Chan; Chyng-Wen Fwu; Jenna M Norton; Paul W Eggers; Kevin C Abbott; Paul L Kimmel
Journal:  J Am Soc Nephrol       Date:  2020-02-20       Impact factor: 10.121

4.  Risk profiles for acute health events after incident atrial fibrillation in patients with end-stage renal disease on hemodialysis.

Authors:  Medha Airy; Tara I Chang; Victoria Y Ding; Benjamin A Goldstein; Nisha Bansal; Jingbo Niu; Sankar D Navaneethan; Mintu P Turakhia; Wolfgang C Winkelmayer
Journal:  Nephrol Dial Transplant       Date:  2018-09-01       Impact factor: 5.992

Review 5.  Oral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial Fibrillation.

Authors:  Austin Hu; Jingbo Niu; Wolfgang C Winkelmayer
Journal:  Semin Nephrol       Date:  2018-11       Impact factor: 5.299

Review 6.  Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction.

Authors:  Tatjana S Potpara; Charles J Ferro; Gregory Y H Lip
Journal:  Nat Rev Nephrol       Date:  2018-03-26       Impact factor: 28.314

Review 7.  Preoperative Noncoronary Cardiovascular Assessment and Management of Kidney Transplant Candidates.

Authors:  Jayson Rakesh Baman; Joseph Knapper; Zankhana Raval; Matthew E Harinstein; John J Friedewald; Kameswari Maganti; Michael J Cuttica; Michael I Abecassis; Ziad A Ali; Mihai Gheorghiade; James D Flaherty
Journal:  Clin J Am Soc Nephrol       Date:  2019-09-25       Impact factor: 8.237

8.  Atrial fibrillation in end stage renal disease patients: influence of hemodialysis on P wave duration and atrial dimension.

Authors:  S Genovesi; P Fabbrini; F Pieruzzi; E Galbiati; E Sironi; D Pogliani; G Bonforte; M R Viganò; A Stella
Journal:  J Nephrol       Date:  2014-08-14       Impact factor: 3.902

9.  Warfarin use and the risk of stroke, bleeding, and mortality in older adults on dialysis with incident atrial fibrillation.

Authors:  Jingwen Tan; Sunjae Bae; Jodi B Segal; Junya Zhu; G Caleb Alexander; Dorry L Segev; Mara McAdams-DeMarco
Journal:  Nephrology (Carlton)       Date:  2019-02       Impact factor: 2.506

10.  Dialysis Modality and Incident Atrial Fibrillation in Older Patients With ESRD.

Authors:  Jingbo Niu; Maulin K Shah; Jose J Perez; Medha Airy; Sankar D Navaneethan; Mintu P Turakhia; Tara I Chang; Wolfgang C Winkelmayer
Journal:  Am J Kidney Dis       Date:  2018-11-16       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.